Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Completed
A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age
NCT05496231· Phase 1/2· GlaxoSmithKline· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error